Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Completed7
Other1

Role Distribution

Principal Investigator8
PI Rate100%

Activity Timeline

Clinical Trials (8)

NCT00877708Completed
Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
E Coli Infections
PrincipalinvestigatorStart date: 2009-03-01
NCT00573235Completed
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
Enterobacteriaceae Infections
PrincipalinvestigatorStart date: 2007-10-01
NCT00414193Completed
Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
AmpC Beta-lactamaseBacteremia
PrincipalinvestigatorStart date: 2007-02-01
NCT00414362Completed
Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
BacteremiaFluoroquinoloneUrinary Tract Infection
PrincipalinvestigatorStart date: 2007-02-01
NCT00177957Completed
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Gram-Negative Bacterial Infections
Principalinvestigator
NCT00363220Completed
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
E Coli InfectionsInfectionKlebsiella Infections+1 more
Principalinvestigator
NCT00619580Withdrawn
Ampicillin-sulbactam Resistant E.Coli at UPMC
Positive E Coli Infections
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David L Paterson, MD

University of Pitttsburgh

Related
2 trials

Shared therapeutic areas:

AmpC Beta-lactamaseBacteremia

Worked with same sponsors:

Japan Health Sciences FoundationUniversity of Pittsburgh
Collaborated on 1 trial
Similarity Score24%

Seetha Shankaran, MD

Wayne State University

Related
49 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Dale L. Phelps, MD

University of Rochester

Related
10 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Michele C. Walsh, MD MS

Case Western Reserve University, Rainbow Babies and Children's Hospital

Related
11 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Urielle Desalbres

Assistance Publique HĂ´pitaux de Marseille

Related
71 trials

Shared therapeutic areas:

InfectionsBacterial Infections
Similarity Score5%

Barbara J. Stoll, MD

Emory University

Related
33 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Richard A. Ehrenkranz, MD

Yale University

Related
31 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Brenda B. Poindexter, MD MS

Indiana University

Related
12 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Edward F. Bell, MD

University of Iowa

Related
11 trials

Shared therapeutic areas:

Gram-Negative Bacterial InfectionsInfections
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT00877708PrincipalInvestigator

Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol

E Coli Infections
Completed
NCT00573235PrincipalInvestigator

Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli

Enterobacteriaceae Infections
Completed
NCT00414193PrincipalInvestigator

Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase

AmpC Beta-lactamaseBacteremia
Completed
NCT00414362PrincipalInvestigator

Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin

BacteremiaFluoroquinoloneUrinary Tract Infection
Completed
NCT00177957PrincipalInvestigator

Gram Negative Bacteremia, Risk Factors for Failure of Therapy

Gram-Negative Bacterial Infections
Completed
NCT00275327PrincipalInvestigator

Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria

Bacterial Infection
Completed
NCT00363220PrincipalInvestigator

Community - Associated Extended-spectrum Beta-lactamases (ESBL)

E Coli InfectionsInfectionKlebsiella Infections+1 more
Completed
NCT00619580PrincipalInvestigator

Ampicillin-sulbactam Resistant E.Coli at UPMC

Positive E Coli Infections
Withdrawn

All 8 trials loaded